Follicular lymphoma transformation to dual translocated Burkitt-like lymphoma: improved disease control associated with radiation therapy.

International Journal of Hematology
Stacey M ParkerTimothy S Fenske

Abstract

Dual translocated (or "dual hit") lymphomas are highly aggressive B cell neoplasms associated with an extremely poor prognosis. The optimal treatment for these lymphomas remains undefined. We present two cases of follicular lymphoma with transformation to Burkitt-like lymphoma. In both cases dual translocations involving both the bcl-2 and c-myc loci were present. Each patient underwent intensive induction immunochemotherapy followed by autologous stem cell transplantation and radiation therapy. The first patient received post-transplant mediastinal radiation and developed recurrence in multiple areas outside of the radiation field. The second patient received total body irradiation as part of the conditioning regimen, and is without recurrence 18 months after transplant, and 24 months after diagnosis of the dual translocated lymphoma. We review dual translocation B cell lymphoma in the setting of transformation from follicular lymphoma, and suggest a potential role for total body irradiation in the management of this highly aggressive non-Hodgkin lymphoma.

References

Mar 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W MillsA H Goldstone
Mar 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I MagrathI D Horak
May 20, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N MacphersonR D Gascoyne
Oct 31, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J L Hecht, J C Aster
Jul 16, 2002·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Naoya NakamuraMasafumi Abe
May 9, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A D ZelenetzC H Moskowitz
Jul 22, 2004·Blood·Kristie A BlumJohn C Byrd
Nov 1, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Anuradha KanungoPei Lin
Jun 9, 2006·The New England Journal of Medicine·Michael HummelUNKNOWN Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe
Jun 9, 2006·The New England Journal of Medicine·Sandeep S DaveUNKNOWN Lymphoma/Leukemia Molecular Profiling Project
Oct 8, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Abdulwahab J Al-TourahJoseph M Connors
Oct 29, 2008·Hematology/oncology Clinics of North America·John W Sweetenham

❮ Previous
Next ❯

Citations

Jul 9, 2011·Diagnostic Pathology·Yu Y HwangChor S Chim
Jun 2, 2011·Journal of Clinical and Experimental Hematopathology : JCEH·Hiroaki TanakaToshiyuki Takagi

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.